Pfizer (PFE) Return on Invested Capital Growth (3y) (2012 - 2026)
Pfizer (PFE) Return on Invested Capital Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 658.50 Bn | 637.74 Bn | 17.26 Bn | 0.00 |
| 2 | AbbVie | 469.32 Bn | 462.75 Bn | 12.70 Bn | 0.00 |
| 3 | Merck | 372.87 Bn | 365.73 Bn | 12.21 Bn | 0.00 |
| 4 | Novartis Ag | 301.29 Bn | 293.60 Bn | 11.24 Bn | -95.00 |
| 5 | Astrazeneca | 256.99 Bn | 252.09 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 237.64 Bn | 223.65 Bn | 7.24 Bn | -1.00 |
| 7 | Gilead Sciences | 181.70 Bn | 178.52 Bn | 6.22 Bn | -1.00 |
| 8 | Pfizer | 159.60 Bn | 147.90 Bn | 10.94 Bn | 1.00 |
| 9 | Gsk | 104.46 Bn | 100.29 Bn | 8.24 Bn | 13.00 |
| 10 | Sanofi | 54.72 Bn | 47.34 Bn | 10.79 Bn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 1.00 |
| Mar 29, 2026 | -6.00 |
| Jun 29, 2025 | -4.00 |
| Mar 30, 2025 | -2.00 |
| Sep 29, 2024 | -2.00 |
| Jun 30, 2024 | -2.00 |
| Mar 31, 2024 | -2.00 |
| Jul 2, 2023 | 1.00 |
| Apr 2, 2023 | 3.00 |
| Jul 3, 2022 | 3.00 |
| Apr 3, 2022 | 3.00 |
| Oct 3, 2021 | 0.00 |
| Jul 4, 2021 | -2.00 |
| Apr 4, 2021 | -3.00 |
| Sep 27, 2020 | -1.00 |
| Jun 28, 2020 | -1.00 |
| Mar 29, 2020 | -1.00 |
| Dec 31, 2019 | -1.00 |
| Sep 29, 2019 | -1.00 |
| Jun 30, 2019 | -1.00 |